IDERA PHARMACEUTICALS INC's ticker is IDRA and the CUSIP is 45168K306. A total of 83 filers reported holding IDERA PHARMACEUTICALS INC in Q1 2017. The put-call ratio across all filers is 3.86 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2017 | $26,000 | -56.7% | 15,076 | -38.3% | 0.02% | -52.0% |
Q1 2017 | $60,000 | +27.7% | 24,417 | -22.0% | 0.05% | +163.2% |
Q4 2016 | $47,000 | +571.4% | 31,319 | +1046.4% | 0.02% | +280.0% |
Q3 2016 | $7,000 | +600.0% | 2,732 | +413.5% | 0.01% | +400.0% |
Q2 2016 | $1,000 | – | 532 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Broadfin Capital, LLC | 3,550,000 | $16,437,000 | 2.17% |
Ghost Tree Capital, LLC | 550,000 | $2,547,000 | 1.57% |
HealthCor Management, L.P. | 3,350,000 | $15,511,000 | 0.94% |
EAM Investors, LLC | 541,969 | $2,509,000 | 0.45% |
Baker Brothers Advisors | 3,171,765 | $14,685,000 | 0.21% |
BOGLE INVESTMENT MANAGEMENT L P /DE/ | 405,729 | $1,878,000 | 0.16% |
Spark Investment Management LLC | 169,000 | $779,000 | 0.14% |
CARL DOMINO INC | 50,137 | $232,000 | 0.13% |
NATIXIS | 3,149,816 | $14,583,000 | 0.12% |
HOLLENCREST CAPITAL MANAGEMENT | 132,000 | $611,000 | 0.10% |